Renukadevi Patil Selected Research

1,2,3,4-tetrahydroisoquinoline

9/2014	EDL-360: A Potential Novel Antiglioma Agent.
6/2012	EDL-291, a novel isoquinoline, presents antiglioblastoma effects in vitro and in vivo.
5/2009	Fast and sensitive liquid chromatography/electrospray mass spectrometry method to study ocular penetration of EDL-155, a novel antitumor agent for retinoblastoma in rats.
10/2008	Effects, in an in-vivo model system, of 1,2,3,4-tetrahydroisoquinoline on glioma.
9/2006	Discovery of antiglioma activity of biaryl 1,2,3,4-tetrahydroisoquinoline derivatives and conformationally flexible analogues.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Renukadevi Patil Research Topics

Disease

22	Neoplasms (Cancer) 01/2019 - 05/2008
6	Glioma (Gliomas) 09/2014 - 09/2006
5	Neoplasm Metastasis (Metastasis) 09/2017 - 05/2011
3	Brain Neoplasms (Brain Tumor) 09/2013 - 05/2008
2	Communicable Diseases (Infectious Diseases) 01/2019 - 01/2017
2	Breast Neoplasms (Breast Cancer) 09/2017 - 11/2014
2	Prostatic Neoplasms (Prostate Cancer) 10/2014 - 08/2012
2	Glioblastoma (Glioblastoma Multiforme) 06/2012 - 05/2009
2	Retinoblastoma (Glioblastoma, Retinal) 07/2010 - 05/2009
1	Rift Valley Fever 01/2019
1	Human Influenza (Influenza) 01/2019
1	Alzheimer Disease (Alzheimer's Disease) 09/2017
1	Ovarian Neoplasms (Ovarian Cancer) 09/2017
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2017
1	Infections 01/2017
1	Virus Diseases (Viral Diseases) 01/2017
1	Inflammation (Inflammations) 03/2016
1	Asthma (Bronchial Asthma) 03/2016
1	Acute Radiation Syndrome 02/2015
1	Body Weight (Weight, Body) 10/2014
1	Carcinogenesis 09/2013
1	Neuralgia (Stump Neuralgia) 09/2013
1	Pruritus (Itching) 09/2013
1	Carcinoma (Carcinomatosis) 05/2011
1	Central Nervous System Neoplasms 05/2008

Drug/Important Bio-Agent (IBA)

5	Pharmaceutical PreparationsIBA 09/2017 - 05/2008
5	1,2,3,4-tetrahydroisoquinolineIBA 09/2014 - 09/2006
4	Lysophosphatidic Acid ReceptorsIBA 03/2016 - 02/2012
4	EDL-155IBA 07/2010 - 05/2008
3	BenzopyransIBA 09/2017 - 07/2012
3	lysophosphatidic acidIBA 03/2016 - 09/2013
2	2-(2,4-dimethylphenyl)indan-1,3-dioneIBA 01/2019 - 01/2017
2	Antiviral Agents (Antivirals)IBA 01/2019 - 01/2017
2	LipidsIBA 03/2016 - 09/2013
2	Androgen Antagonists (Antiandrogens)IBA 10/2014 - 08/2012
2	N- (4- cyano- 3- (trifluoromethyl)phenyl)- 3- ((4- cyanophenyl)(methyl)amino)- 2- hydroxy- 2- methylpropanamideIBA 10/2014 - 08/2012
2	embelinIBA 09/2014 - 08/2012
2	Antineoplastic Agents (Antineoplastics)IBA 10/2012 - 05/2009
2	Acridine OrangeIBA 06/2012 - 07/2010
1	Chalcone (Benzalacetophenone)IBA 01/2019
1	AcetylcholinesteraseIBA 09/2017
1	Donepezil (Aricept)FDA LinkGeneric 09/2017
1	IndansIBA 09/2017
1	Therapeutic UsesIBA 09/2017
1	Adenosine Triphosphatases (ATPase)IBA 09/2017
1	Proton Pumps (Proton Pump)IBA 09/2017
1	Adenosine Triphosphate (ATP)IBA 09/2017
1	5,6-dimethoxyindan-1-oneIBA 01/2017
1	Benzoic Acid (Potassium Benzoate)FDA Link 03/2016
1	AllergensIBA 03/2016
1	resiquimodIBA 01/2016
1	Imiquimod (Aldara)FDA LinkGeneric 01/2016
1	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2016
1	TOR Serine-Threonine KinasesIBA 01/2016
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2015
1	Monoclonal AntibodiesIBA 11/2014
1	IntegrinsIBA 11/2014
1	MicellesIBA 10/2014
1	Prostate-Specific Antigen (Semenogelase)IBA 10/2014
1	Caspase 3 (Caspase-3)IBA 10/2014
1	Gonadotropin-Releasing Hormone (GnRH)FDA Link 10/2014
1	crolibulinIBA 09/2013
1	alkylglycerophosphoethanolamine phosphodiesteraseIBA 09/2013
1	TubulinIBA 10/2012
1	X-Linked Inhibitor of Apoptosis ProteinIBA 08/2012
1	Androgen Receptors (Androgen Receptor)IBA 08/2012
1	EDL-291IBA 06/2012
1	isoquinolineIBA 07/2010
1	LuciferasesIBA 07/2010
1	1- (biphenyl- 4- ylmethyl)- 1,2,3,4- tetrahydroisoquinoline- 6,7- diolIBA 10/2008
1	SolutionsIBA 10/2008
1	TetrahydroisoquinolinesIBA 05/2008
1	diphenyl (biphenyl)IBA 09/2006

Therapy/Procedure

9	Therapeutics 01/2019 - 05/2009
2	Drug Therapy (Chemotherapy) 09/2013 - 05/2011
1	Aftercare (After-Treatment) 06/2012
1	Intraocular Injections 07/2010
1	Intraperitoneal Injections 10/2008